Prevention of ovarian hyperstimulation syndrome.
Amso
N N
NN
Shaw
R W
RW
Ahuja
K K
KK
Morris
N
N
D006063:Chorionic Gonadotropin / Q000009:adverse effects* / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D004359:Drug Therapy, Combination; D005260:Female; D005307:Fertilization in Vitro; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D010049:Ovarian Diseases / Q000139:chemically induced / Q000517:prevention & control*; D010053:Ovary / Q000187:drug effects; D010062:Ovulation Induction / Q000379:methods*; D013577:Syndrome; D017329:Triptorelin Pamoate / Q000031:analogs & derivatives*
D006063:Chorionic Gonadotropin; D003692:Delayed-Action Preparations; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; C019176:Tryptal